Neurobiology of dopamine in schizophrenia - PubMed (original) (raw)
Review
Neurobiology of dopamine in schizophrenia
Olivier Guillin et al. Int Rev Neurobiol. 2007.
Abstract
This chapter is an update on the dopamine (DA) imbalance in schizophrenia, including the evidence for subcortical hyperstimulation of D2 receptors underlying positive symptoms and cortical hypodopaminergia-mediating cognitive disturbances and negative symptoms. After a brief review of the anatomical neurocircuitry of this transmitter system as a background, we summarize the evidence for dopaminergic alterations deriving from pharmacological, postmortem, and imaging studies. This evidence supports a prominent role for D2 antagonism in the treatment of positive symptoms of schizophrenia and strongly suggests the need for alternative approaches to address the more challenging problem of negative symptoms and cognitive disturbances.
Similar articles
- The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
Goto Y, Grace AA. Goto Y, et al. Int Rev Neurobiol. 2007;78:41-68. doi: 10.1016/S0074-7742(06)78002-3. Int Rev Neurobiol. 2007. PMID: 17349857 Review. - Molecular brain imaging and the neurobiology and genetics of schizophrenia.
Heinz A, Romero B, Gallinat J, Juckel G, Weinberger DR. Heinz A, et al. Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S152-7. doi: 10.1055/s-2003-45123. Pharmacopsychiatry. 2003. PMID: 14677072 Review. - Dopamine receptor excess and mouse madness.
Snyder SH. Snyder SH. Neuron. 2006 Feb 16;49(4):484-5. doi: 10.1016/j.neuron.2006.02.002. Neuron. 2006. PMID: 16476659 - Pathway-Specific Dopamine Abnormalities in Schizophrenia.
Weinstein JJ, Chohan MO, Slifstein M, Kegeles LS, Moore H, Abi-Dargham A. Weinstein JJ, et al. Biol Psychiatry. 2017 Jan 1;81(1):31-42. doi: 10.1016/j.biopsych.2016.03.2104. Epub 2016 Mar 31. Biol Psychiatry. 2017. PMID: 27206569 Free PMC article. Review. - Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
Marek GJ. Marek GJ. Int Rev Neurobiol. 2007;78:165-92. doi: 10.1016/S0074-7742(06)78006-0. Int Rev Neurobiol. 2007. PMID: 17349861 Review.
Cited by
- Patterns of brain structural changes in first-contact, antipsychotic drug-naive patients with schizophrenia.
Filippi M, Canu E, Gasparotti R, Agosta F, Valsecchi P, Lodoli G, Galluzzo A, Comi G, Sacchetti E. Filippi M, et al. AJNR Am J Neuroradiol. 2014 Jan;35(1):30-7. doi: 10.3174/ajnr.A3583. Epub 2013 Jun 6. AJNR Am J Neuroradiol. 2014. PMID: 23744689 Free PMC article. - Cholinergic connectivity: it's implications for psychiatric disorders.
Scarr E, Gibbons AS, Neo J, Udawela M, Dean B. Scarr E, et al. Front Cell Neurosci. 2013 May 3;7:55. doi: 10.3389/fncel.2013.00055. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23653591 Free PMC article. - Class A and C GPCR Dimers in Neurodegenerative Diseases.
Caniceiro AB, Bueschbell B, Schiedel AC, Moreira IS. Caniceiro AB, et al. Curr Neuropharmacol. 2022;20(11):2081-2141. doi: 10.2174/1570159X20666220327221830. Curr Neuropharmacol. 2022. PMID: 35339177 Free PMC article. Review. - Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.
O'Tuathaigh CM, Kirby BP, Moran PM, Waddington JL. O'Tuathaigh CM, et al. Schizophr Bull. 2010 Mar;36(2):271-88. doi: 10.1093/schbul/sbp125. Epub 2009 Nov 24. Schizophr Bull. 2010. PMID: 19934211 Free PMC article. - Modulating the granularity of category formation by global cortical States.
Kim Y, Vladimirskiy BB, Senn W. Kim Y, et al. Front Comput Neurosci. 2008 Jun 3;2:1. doi: 10.3389/neuro.10.001.2008. eCollection 2008. Front Comput Neurosci. 2008. PMID: 18946531 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical